Evans M Blake, Hosseinzadeh Pardis, Flannagan Kerry, Jahandideh Samad, Burruss Emilie, Peck Jennifer D, Hansen Karl R, Hill Micah, Devine Kate
Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Fertil Steril. 2024 Jul;122(1):114-120. doi: 10.1016/j.fertnstert.2024.02.018. Epub 2024 Feb 15.
To study the primary objective of clinical pregnancy (CP) rate per ovarian stimulation with intrauterine insemination (OS-IUI) treatment cycle in patients with repetitive cycles up to a maximum of 8 cycles.
Retrospective cohort.
Large fertility clinic.
A total of 37,565 consecutive OS-IUI cycles from 18,509 patients were included in this study.
Those with anovulatory diagnoses, tubal factor infertility, male factor infertility, using donor sperm, canceled cycles, and those with missing data for either baseline characteristics or outcome were excluded. The CP rate was analyzed using generalized estimating equations and controlled for age, stimulation protocol, and body mass index.
Clinical pregnancy was defined as intrauterine gestation with fetal heartbeat visible on ultrasound.
A total of 37,565 consecutive OS-IUI cycles from 2002 through 2019 at a private practice facility were evaluated. All cycles met inclusion criteria and were used in generalized estimating equation modeling. Patients aged <35 years comprised 47.6% of the cohort. After adjustment for confounders, the mean predicted probability of CP for cycles one to 8 was 15.7% per cycle. The mean predicted probability of CP in aggregated data from cycles 2 to 4 was only 1.7% lower compared with cycle 1 as the referent (16.7% vs. 15.0%, 95% confidence interval [CI] 2nd: 0.88 {0.82, 0.95}, 3rd: 0.86 {0.79, 0.93}, 4th: 0.88 {0.79, 0.98}). However, the 15.0% mean predicted probability of CP for the second through the fourth cycle was concordant with the mean for all included cycles (15.7%). The mean predicted probability of CP of cycles 5 to 8 was not significantly different compared with the referent (16.7% vs. 16.1%, 95% CI 5th: 0.97 [0.85, 1.11], 6th: 0.93 [0.79, 1.10], 7th: 1.01 [0.81, 1.26], 8th: 1.01 [0.76, 1.34]). The modeling of consecutive cycles suggested that the adjusted cumulative predicted probability of CP from OS-IUI continues to increase with each of the 8 successive cycles.
Clinical pregnancy rates are satisfactory in up to 8 consecutive OS-IUI treatment cycles. These data are useful for counseling, especially in those patients for whom in vitro fertilization is not financially or ethically feasible.
研究重复进行宫内人工授精(OS-IUI)治疗周期(最多8个周期)的患者每次卵巢刺激后的临床妊娠(CP)率这一主要目标。
回顾性队列研究。
大型生育诊所。
本研究纳入了来自18509名患者的总共37565个连续的OS-IUI周期。
排除无排卵诊断、输卵管因素不孕、男性因素不孕、使用供精、取消周期以及基线特征或结局数据缺失的患者。使用广义估计方程分析CP率,并对年龄、刺激方案和体重指数进行控制。
临床妊娠定义为超声可见胎心的宫内妊娠。
对一家私人诊所2002年至2019年的总共37565个连续的OS-IUI周期进行了评估。所有周期均符合纳入标准,并用于广义估计方程建模。年龄<35岁的患者占队列的47.6%。在对混杂因素进行调整后,第1至8个周期的CP平均预测概率为每个周期15.7%。以第1个周期作为对照,第2至4个周期汇总数据中的CP平均预测概率仅低1.7%(16.7%对15.0%,95%置信区间[CI]:第2个:0.88{0.82, 0.95},第3个:0.86{0.79, 0.93},第4个:0.88{0.79, 0.98})。然而,第2至4个周期15.0%的CP平均预测概率与所有纳入周期的平均值(15.7%)一致。第5至8个周期的CP平均预测概率与对照相比无显著差异(16.7%对16.1%,95%CI:第5个:0.97[0.85, 1.11],第6个:0.93[0.79, 1.10],第7个:1.01[0.81, 1.26],第8个:1.01[0.76, 1.34])。连续周期的建模表明,OS-IUI的CP调整后累积预测概率在连续的8个周期中每个周期都持续增加。
连续8个OS-IUI治疗周期的临床妊娠率令人满意。这些数据有助于咨询,特别是对于那些体外受精在经济或伦理上不可行的患者。